Juan A Lopez
Overview
Explore the profile of Juan A Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jurcic E, Villalba P, Pathauer P, Palazzini D, Oberschelp G, Harrand L, et al.
Heredity (Edinb)
. 2021 Jun;
127(2):176-189.
PMID: 34145424
Genomic selection based on the single-step genomic best linear unbiased prediction (ssGBLUP) approach is becoming an important tool in forest tree breeding. The quality of the variance components and the...
12.
Toribio-Fernandez R, Herrero-Fernandez B, Zorita V, Lopez J, Vazquez J, Criado G, et al.
J Pathol
. 2019 Aug;
249(4):509-522.
PMID: 31372995
The mechanisms by which lamin A/C in CD4 T-cells control intestinal homeostasis and can cause inflammatory bowel disease (IBD) are unknown. Here, we explore lamin A/C in a mouse model...
13.
Crevillen P, Gomez-Zambrano A, Lopez J, Vazquez J, Pineiro M, Jarillo J
New Phytol
. 2019 Feb;
222(4):1893-1908.
PMID: 30742710
Posttranslational histone modifications and the dynamics of histone variant H2A.Z are key mechanisms underlying the floral transition. In yeast, SWR1-C and NuA4-C mediate the deposition of H2A.Z and the acetylation...
14.
Martin-Lorenzo M, Martinez P, Baldan-Martin M, Lopez J, Minguez P, Santiago-Hernandez A, et al.
Hypertension
. 2019 Feb;
73(4):794-802.
PMID: 30712426
Resistant hypertension prevalence is progressively increasing, and prolonged exposure to suboptimal blood pressure control results in higher cardiovascular risk and end-organ damage. Among various antihypertensive agents, spironolactone seems the most...
15.
Martinez P, Baldan-Martin M, Lopez J, Martin-Lorenzo M, Santiago-Hernandez A, Agudiez M, et al.
Atherosclerosis
. 2019 Jan;
282:67-74.
PMID: 30690299
Background And Aims: The predictive value of traditional CV risk calculators is limited. Novel indicators of CVD progression are needed particularly in the young population. The main aim of this...
16.
Martinez-Cuadron D, Gil C, Serrano J, Rodriguez G, Perez-Oteyza J, Garcia-Boyero R, et al.
Leuk Res
. 2018 Nov;
76:1-10.
PMID: 30468991
Complete remission (CR) after induction therapy is the first treatment goal in acute myeloid leukemia (AML) patients and has prognostic impact. Our purpose is to determine the correlation between the...
17.
Gomez-Zambrano A, Crevillen P, Franco-Zorrilla J, Lopez J, Moreno-Romero J, Roszak P, et al.
Mol Plant
. 2018 Apr;
11(6):815-832.
PMID: 29604400
Deposition of the H2A.Z histone variant by the SWR1 complex (SWR1-C) in regulatory regions of specific loci modulates transcription. Characterization of mutations in Arabidopsis thaliana homologs of yeast SWR1-C has...
18.
Baldan-Martin M, Lopez J, Corbacho-Alonso N, Martinez P, Rodriguez-Sanchez E, Mourino-Alvarez L, et al.
Sci Rep
. 2018 Mar;
8(1):4802.
PMID: 29555916
The evaluation of cardiovascular (CV) risk is based on equations derived from epidemiological data in individuals beyond the limits of middle age such as the Framingham and SCORE risk assessments....
19.
Fiuza-Luces C, Santos-Lozano A, Llavero F, Campo R, Nogales-Gadea G, Diez-Bermejo J, et al.
J Physiol
. 2018 Jan;
596(6):1035-1061.
PMID: 29315579
Key Points: Although they are unable to utilize muscle glycogen, McArdle mice adapt favourably to an individualized moderate-intensity endurance exercise training regime. Yet, they fail to reach the performance capacity...
20.
de la Cuesta F, Baldan-Martin M, Moreno-Luna R, Alvarez-Llamas G, Gonzalez-Calero L, Mourino-Alvarez L, et al.
Oncotarget
. 2017 Feb;
8(9):15553-15562.
PMID: 28152519
Despite of the great advances in anti-hypertensive therapies, many patients under Renin-Angiotensin- System (RAS) suppression develop albuminuria, which is a clear indicator of therapeutic inefficiency. Hence, indicators of vascular function...